3-FMA

3-Fluoromethamphetamine (3-FMA) is a synthetic stimulant design drug from the substituted amphetamine class (chemical name). It is a derivative of methamphetamine, structurally characterized by a fluorine atom at the meta (3-) position of its phenyl ring (structural detail).

Chemsrc describes 3-FMA as a monoamine releaser that primarily affects the dopamine and norepinephrine systems, producing stimulant and euphoriant effects (mechanism of action).

Studies have shown that 3-FMA produces dose-dependent increases in locomotor activity and has rewarding and reinforcing properties in animal models, suggesting a potential for abuse comparable to other psychostimulants like methamphetamine (abuse potential). Its use has been associated with significant adverse effects, including the potential for heart failure, cerebral hemorrhage, and death (health effects).

The hydrochloride salt form of 3-FMA is a crystalline solid, and it is typically used and sold for forensic and research purposes in regulated laboratory settings (physical form). It is a controlled substance in several countries, including Canada, the United Kingdom, and China, and its unscheduled status in the US means it can potentially be prosecuted under the Federal Analogue Act (legal status).